Tania A. Rozgaja Stallons
Tania A. Rozgaja Stallons publishes mostly in Radiology, Nuclear Medicine and Imaging, Epidemiology and Oncology, on topics such as Radiopharmaceutical Chemistry and Applications, Neuroendocrine Tumor Research Advances and Lung Cancer Research Studies.
- World rank
- #2,583,786 of 7,710,434 ranked researchers
- Rank in United States
- #758,580 of 1,627,098
- Works
- 32
- Citations
- 170
- Citations per work
- 5.3
What does Tania A. Rozgaja Stallons research?
Tania A. Rozgaja Stallons's work is mostly in Medicine (85%), Materials Science (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2784.8%
- Medicine2784.8%
- Everything else310.9%
- Physical Sciences14.3%
- Materials Science14.3%
- 1Radiology, Nuclear Medicine and Imaging30% of their works
- 2Epidemiology20% of their works
- 3Oncology15% of their works
- 4Pulmonary and Respiratory Medicine11% of their works
- 5Neurology9% of their works
- 6Materials Chemistry4% of their works
Research topics
- Radiopharmaceutical Chemistry and Applications
- Neuroendocrine Tumor Research Advances
- Lung Cancer Research Studies
- Neuroblastoma Research and Treatments
- Lung Cancer Treatments and Mutations
- Monoclonal and Polyclonal Antibodies Research
- Medical Device Sterilization and Disinfection
- Radioactive element chemistry and processing
Which keywords describe Tania A. Rozgaja Stallons's research?
The keywords of their largest research topics: Targeted Therapy, Genetic Mutations, PET Imaging, Radiopharmaceuticals, Immunotherapy, Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors and Clinical Trials.
- Uranium
- Endoscope
- Therapeutic Antibodies
- EGFR Mutations
- Neuroblastoma
- Small-Cell Lung Cancer
- Clinical Trials
- Neuroendocrine Tumors
- Radiopharmaceuticals
- Genetic Mutations
- Targeted Therapy
- PET Imaging
- Immunotherapy
- Pancreatic Neuroendocrine Tumors
- Genomic Profiles
- ALK
- ALK Inhibitors
- Fc Receptors
- Actinides
- Infection
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Targeted Therapy183 topics
- Genetic Mutations132 topics
- PET Imaging111 topic
- Radiopharmaceuticals111 topic
- Immunotherapy92 topics
- Neuroendocrine Tumors91 topic
- Pancreatic Neuroendocrine Tumors91 topic
- Clinical Trials72 topics
- Genomic Profiles51 topic
- Small-Cell Lung Cancer51 topic
- ALK41 topic
- Neuroblastoma41 topic
- ALK Inhibitors21 topic
- EGFR Mutations21 topic
- Fc Receptors21 topic
- Therapeutic Antibodies21 topic
- Actinides11 topic
- Endoscope11 topic
- Infection11 topic
- Uranium11 topic
Where does Tania A. Rozgaja Stallons work?
Tania A. Rozgaja Stallons's main affiliation in the publication record is Plano Cancer Institute, United States.
How many publications and citations does Tania A. Rozgaja Stallons have?
OpenAlex counts 32 works and 170 citations for Tania A. Rozgaja Stallons, an h-index of 5, ranking #2,583,786 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tania A. Rozgaja Stallons. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.